These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20569983)

  • 61. Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine.
    Sato K; Tsukada N; Inamura J; Komatsu S; Sato K; Yamamoto M; Shindo M; Moriichi K; Mizukami Y; Fujiya M; Torimoto Y; Okumura T
    Case Rep Hematol; 2021; 2021():6640597. PubMed ID: 33976945
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phosphorylation of Human Retinoid X Receptor α at Serine 260 Impairs Its Subcellular Localization, Receptor Interaction, Nuclear Mobility, and 1α,25-Dihydroxyvitamin D3-dependent DNA Binding in Ras-transformed Keratinocytes.
    Jusu S; Presley JF; Kremer R
    J Biol Chem; 2017 Jan; 292(4):1490-1509. PubMed ID: 27852823
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transfusion-transmitted hepatitis E in a patient with myelodysplastic syndromes.
    Kimura Y; Gotoh A; Katagiri S; Hoshi Y; Uchida S; Yamasaki A; Takahashi Y; Fukutake K; Kiguchi T; Ohyashiki K
    Blood Transfus; 2014 Jan; 12(1):103-6. PubMed ID: 24120594
    [No Abstract]   [Full Text] [Related]  

  • 64. Clinical experience using vitamin d and analogs in the treatment of myelodysplasia and acute myeloid leukemia: a review of the literature.
    Harrison JS; Bershadskiy A
    Leuk Res Treatment; 2012; 2012():125814. PubMed ID: 23198150
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combined treatment of leukemia cells with vitamin K2 and 1alpha,25-dihydroxy vitamin D3 enhances monocytic differentiation along with becoming resistant to apoptosis by induction of cytoplasmic p21CIP1.
    Iguchi T; Miyazawa K; Asada M; Gotoh A; Mizutani S; Ohyashiki K
    Int J Oncol; 2005 Oct; 27(4):893-900. PubMed ID: 16142303
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
    Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Menatetrenone, a vitamin K2 analog, ameliorates cytopenia in patients with refractory anemia of myelodysplastic syndrome.
    Takami A; Asakura H; Nakao S
    Ann Hematol; 2002 Jan; 81(1):16-9. PubMed ID: 11807630
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Vitamin K2 therapy for myelodysplastic syndrome].
    Abe Y; Muta K; Hirase N; Choi I; Matsushima T; Hara K; Taguchi F; Suematsu E; Shibata K; Uike N; Nishimura J; Nawata H
    Rinsho Ketsueki; 2002 Feb; 43(2):117-21. PubMed ID: 11925874
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intensive chemotherapy for patients with high-risk myelodysplastic syndrome.
    Beran M
    Int J Hematol; 2000 Aug; 72(2):139-50. PubMed ID: 11039661
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multicenter phase II trial of vitamin K(2) monotherapy and vitamin K(2) plus 1alpha-hydroxyvitamin D(3) combination therapy for low-risk myelodysplastic syndromes.
    Akiyama N; Miyazawa K; Kanda Y; Tohyama K; Omine M; Mitani K; Ohyashiki K
    Leuk Res; 2010 Sep; 34(9):1151-7. PubMed ID: 20569983
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.